NCT05603039 2022-11-02A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular CarcinomaQilu Pharmaceutical Co., Ltd.Phase 1/2 Unknown80 enrolled
NCT04163237 2019-11-14Combined Immunotherapy and Targeted Therapy for Advanced Liver CancerGuangxi Medical UniversityPhase 3 Unknown50 enrolled